Found 6 matching trials
ACTIV-2: A Study for Outpatients With COVID-19 PHASE2 Drug studies often look at the effect one or two drugs have on a medical co...
Show More Location
Pinnacle Research Group (Site 1082), 321 E. 10th Street
Learn More & Join Trial
Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults PHASE3 This study will assess the efficacy of AZD7442 for the post-exposure prophy...
Show More Learn More & Join Trial
Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults PHASE3 This Phase III study will assess whether AZD7442 (a combination of 2 mAbs) ...
Show More Learn More & Join Trial
Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult. PHASE3 This study will assess the safety and efficacy of a single dose of AZD7442(...
Show More Learn More & Join Trial
Parent Study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA Sub-study) PHASE2 AZD3152, a single mAb, is being developed to have broad neutralizing activi...
Show More Learn More & Join Trial
AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19 PHASE1 In this first-in-humans dose escalation study, AZD7442 (AZD8895 + AZD1061) ...
Show More Learn More & Join Trial